Ascentage Pharma Group International (AAPG) Non-Current Assets (2023 - 2025)

Historic Non-Current Assets for Ascentage Pharma Group International (AAPG) over the last 3 years, with Q2 2025 value amounting to $158.8 million.

  • Ascentage Pharma Group International's Non-Current Assets changed N/A to $158.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $158.8 million, marking a year-over-year change of. This contributed to the annual value of $156.7 million for FY2024, which is 423.46% down from last year.
  • As of Q2 2025, Ascentage Pharma Group International's Non-Current Assets stood at $158.8 million.
  • In the past 5 years, Ascentage Pharma Group International's Non-Current Assets registered a high of $160.6 million during Q4 2023, and its lowest value of $158.8 million during Q2 2025.
  • For the 3-year period, Ascentage Pharma Group International's Non-Current Assets averaged around $159.5 million, with its median value being $159.2 million (2024).
  • Within the past 5 years, the most significant YoY rise in Ascentage Pharma Group International's Non-Current Assets was 85.31% (2024), while the steepest drop was 85.31% (2024).
  • Ascentage Pharma Group International's Non-Current Assets (Quarter) stood at $160.6 million in 2023, then dropped by 0.85% to $159.2 million in 2024, then fell by 0.27% to $158.8 million in 2025.
  • Its Non-Current Assets was $158.8 million in Q2 2025, compared to $159.2 million in Q4 2024 and $160.6 million in Q4 2023.